Court Paves Way for Nutrien/Tianqi Deal

Chile’s Constitutional Court declined Oct. 25 to take up a case questioning whether an agreement between China’s Tianqi Lithium Corp. and Chile’s antitrust agency Fiscalia Nacional Economica (FNE) went far enough to protect SQM’s trade secrets against its Chinese competitor (GM Oct. 12, p. 25). Tianqi Lithium has agreed to acquire a 24 percent stake in SQM from Nutrien Ltd., Saskatoon, for $4.1 billion.

In a joint statement, Tianqi Lithium and Nutrien said they were pleased with the court decision. It allows the Tribunal de Defensa de la Libre Competencia (TDLC) to rule on the reconsideration motions filed by the Pampa Group, SQM and Conadecus against the TDLC’s initial decision (GM Sept. 14, p. 25, Sept. 21, p. 1). TDLC’s initial decision upheld Tianqi Lithium’s agreement with FNE to allow the deal to proceed.

Nutrien and Tianqi Lithium expect to close the sale by the end of the year as previously planned.

CVR Shrinks Loss

CVR Partners LP, Sugar Land, Texas, reported a third-quarter net loss of $13 million on net sales of $80 million, compared a year-ago net loss of $32 million on net sales of $69 million.

“We are pleased to report strong operating performance and improved fertilizer netbacks at both our Coffeyville, Kan., and East Dubuque, Ill., fertilizer facilities during the 2018 third quarter,” said Mark Pytosh, CVR CEO. “Market conditions have continued to improve since summer and we are seeing strong global demand for nitrogen fertilizer. In addition, product pricing for the late fall of 2018 has increased by approximately 25 percent from the summer fill season and we’re seeing continued pricing strength into the first quarter of 2019.”

Disclaimer of Warranty
All information has been obtained by Green Markets from sources believed to be reliable. However, because of the possibility of human or mechanical error by our sources, Green Markets or others, Green Markets does not guarantee the accuracy, adequacy, or completeness of any information and is not responsible for any errors or omissions or for the results obtained from the use of such information.

For additional details visit our Terms of Use.